Allergy, eczema common after pediatric solid organ transplantation

Factors that appeared unlinked with PTAA included acute organ rejection, duration of posttransplantation steroidal treatment, organ type (living versus cadaveric), donor/recipient blood type and compatibility, infections besides Epstein-Barr virus, and posttransplant lymphoproliferative disease. “The specific type of post-transplantation immunosuppression regimen was neither associated nor protective of PTAA,” the investigators wrote. “However, a significant limitation was our inability to assess the effect of tacrolimus, as nearly all the cohort (97.8%) was treated with this medication.”

Ashley’s Angels fund provided support. The researchers reported having no conflicts of interest.

SOURCE: Marcus N et al. J Pediatr. 2018;196:154-60.